Previous Close | 53.64 |
1-Year Change | 124.81% |
6-Months Change | 35.18% |
3-Months Change | 31.86% |
Moving Avg (50d) | 47.861 |
Moving Avg (200d) | 43.393 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 3.17B |
Beta (3-Years) | 1.28 |
Revenue Growth (ttm) | 271.94% |
Net Profit Margin (ttm) | -299.33% |
Return On Assets (ttm) | -52.38% |
EPS (ttm) | -3.24 |
PE Ratio (ttm) | -16.56 |
Dividend Yield | % |
Asset Description: | Rhythm Pharmaceuticals, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-09 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
52.567 | 50.958 | 49.885 | 48.276 | 45.594 | 42.912 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |